Status:
COMPLETED
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Measuring levels of calgranulin A and calgranulin B in the blood of patients with breast cancer in the laboratory may help doctors identify and learn more about biomarkers related to breast...
Detailed Description
OBJECTIVES: * Determine circulating levels of calgranulin A and calgranulin B in patients with estrogen receptor negative or estrogen receptor positive, newly diagnosed, primary stage I-III adenocarc...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed primary adenocarcinoma of the breast
- Stage I-III disease
- No evidence of metastatic disease
- Newly diagnosed disease
- Hormone receptor status:
- Estrogen receptor-positive- or -negative tumor
- PATIENT CHARACTERISTICS:
- Sex
- Not specified
- Menopausal status
- Not specified
- Performance status
- Not specified
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- Other
- Not pregnant
- No Crohn's disease
- No arthritis
- No psoriasis
- No lupus erythematosus
- No multiple sclerosis
- No other severe active inflammation
- Not C-reactive protein positive
- No HIV positivity
- No other serious medical or psychiatric illness
- PRIOR CONCURRENT THERAPY:
- Radiotherapy
- No prior radiotherapy for breast cancer
- Surgery
- No prior organ transplantation
- Other
- No prior systemic therapy for breast cancer
Exclusion
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00900133
Start Date
January 1 2005
End Date
December 1 2006
Last Update
October 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44106